Package 68071-3594-3

Brand: bupropion hydrochloride xl

Generic: bupropion hydrochloride
NDC Package

Package Facts

Identity

Package NDC 68071-3594-3
Digits Only 6807135943
Product NDC 68071-3594
Product ID 68071-3594_15ad1da5-913c-665c-e063-6394a90a9056
Description

30 TABLET, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (68071-3594-3)

Marketing

Marketing Status
Marketed Since 2024-04-09
Brand bupropion hydrochloride xl
Generic bupropion hydrochloride
Sample Package No

Linked Drug Pages (1)

Bupropion Hydrochloride XL ndc-match (0.95)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["ORAL"], "spl_id": "15ad1da5-913c-665c-e063-6394a90a9056", "openfda": {"upc": ["0368071359435"], "unii": ["ZG7E5POY8O"], "rxcui": ["993541"], "spl_set_id": ["15ad0c66-1829-59c3-e063-6394a90a4384"], "manufacturer_name": ["NuCare Pharmacueticals, Inc."]}, "finished": true, "packaging": [{"sample": false, "description": "30 TABLET, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (68071-3594-3)", "package_ndc": "68071-3594-3", "marketing_start_date": "20240409"}], "brand_name": "Bupropion Hydrochloride XL", "product_id": "68071-3594_15ad1da5-913c-665c-e063-6394a90a9056", "dosage_form": "TABLET, EXTENDED RELEASE", "pharm_class": ["Aminoketone [EPC]", "Dopamine Uptake Inhibitors [MoA]", "Increased Dopamine Activity [PE]", "Increased Norepinephrine Activity [PE]", "Norepinephrine Uptake Inhibitors [MoA]"], "product_ndc": "68071-3594", "generic_name": "bupropion hydrochloride", "labeler_name": "NuCare Pharmacueticals, Inc.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Bupropion Hydrochloride", "brand_name_suffix": "XL", "active_ingredients": [{"name": "BUPROPION HYDROCHLORIDE", "strength": "150 mg/1"}], "application_number": "ANDA210015", "marketing_category": "ANDA", "marketing_start_date": "20230430", "listing_expiration_date": "20261231"}